Altimmune share price logo

Altimmune

NASDAQ: ALT

Small Cap

$2.94

-0.18

(-5.77%)

Live

as on

Altimmune Stock Performance

as on August 21, 2026 at 5:27 am IST

  • Day's Low

    Day's High

    $2.92
    $3.08
    downward going graph

    0.68%

    Downside

    4.76%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.56
    $6.44
    downward going graph

    12.93%

    Downside

    119.04%

    Upside

    downward going graph

Altimmune share price movements today

Previous Close
$3.12
Open
$3.07
Volume
3.5M
Market Cap
$571.9M
Day's Low - High
$2.92 - $3.08
52 Week Low - High
$2.56 - $6.44

Altimmune Historical Returns

1 Month Return
+ 2.44 %
3 Month Return
+ 3.16 %
1 Year Return
-19.01 %
3 Year Return
+ 9.29 %
5 Year Return
-75.6 %

Altimmune Stock Fundamentals & Key Indicators

Check Altimmune market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$571.9M

EPS (TTM)

-0.78

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.69

Industry PE ratio

-7.283372093023256

PEG Ratio

-0.08020999594079663

EBITDA

-88.1M

Revenue (TTM)

31.0K

Profit Margin

-48232.26%

Return On Equity TTM

-31.41%

Altimmune Stock Valuation

Track how Altimmune P/E has moved over time to understand its valuation trends.

Altimmune in the last 5 years

  • Overview

  • Trends

Lowest (-9.11x)

December 31, 2022

Industry (-7.28x)

December 31, 2025

Today (-3.61x)

December 31, 2025

Highest (-3.61x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -3.61x

Altimmune vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Altimmune with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$571.9M-75.6%-3.69-48232.26%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Altimmune Stock including INR - Dollar returns

The Altimmune stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Altimmune investment value today

Current value as on today

₹89,068

Returns

-₹10,932

(-10.93%)

Returns from Altimmune Stock

-₹19,008 (-19.01%)

Dollar Impact

₹8,076 (+8.08%)

Analyst Recommendation on Altimmune Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Altimmune. Average target price of $17.22

Altimmune Share Price Target

Get share price movements and forecasts by analysts on Altimmune.

What analysts predicted

82.93%UPSIDE

Target Price

$17.22

Current Price

$2.94

Analyzed by

5 Analysts

Target

$17.22

Altimmune target price $17.22, a slight upside of 82.93% compared to current price of $2.94. According to 5 analysts rating.

Indian Investors' Interest in Altimmune Stock

Search interest for Altimmune Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:11% versus previous 30 day period

Altimmune Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
0
-
-
Gross Profit
0
0
0
0
0
0
-14
0
0
-
Operating Income
-26
-26
-24
-24
-21
-22
-20
-28
-24
-26
EBITDA
-24
-24
-22
-23
-20
-21
-18
-26
-21
-21
Interest Expense
0
0
0
0
0
0
0
0
1
1
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-24
-24
-22
-23
-20
-22
-19
-27
-22
-22
Income Tax Expense
-
-
-
-
0
-
-
-
-
-
Net Income
-24
-24
-22
-23
-19
-22
-19
-27
-22
-22
Net Profit Margin
-2040.00%
100.00%
100.00%
100.00%
100.00%
100.00%
-299100.00%
100.00%
0.00%
0.00%

Altimmune Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
10
5
8
4
0
0
0
0
Gross Profit
-18
-8
5
-25
4
0
0
0
0
Operating Income
-52
-42
-21
-54
-96
-87
-95
-103
-94
EBITDA
-51
-44
-20
-38
-96
-84
-87
-94
-87
Interest Expense
0
0
0
0
0
0
0
0
1
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-52
-45
-20
-43
-97
-84
-88
-95
-88
Income Tax Expense
-5
-6
0
5
-
0
-
-
0
Net Income
-46
-39
-20
-49
-97
-84
-88
-95
-88
Net Profit Margin
-44249.39%
-78.68%
100.00%
-309.40%
100.00%
100.00%
100.00%
100.00%
100.00%

Altimmune Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-24
-24
-22
-23
-19
-22
-19
-27
-22
-22
Operating Cash Flow
-16
-18
-27
-18
-16
-19
-11
-19
-20
-24
Investing Cash Flow
-39
-3
1
13
-5
101
-149
-79
-3
-221
Financing Cash Flow
0
0
0
10
34
52
39
81
78
211
Change in Cash
-56
-21
-25
5
12
134
-121
-17
53
-34

Altimmune Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-46
-39
-20
-49
-97
-84
-88
-95
-88
Operating Cash Flow
-20
-9
-9
-34
-78
-62
-75
-79
-67
Investing Cash Flow
13
-1
-28
-72
87
-73
13
-28
-132
Financing Cash Flow
15
32
12
213
65
56
86
10
206
Change in Cash
9
22
-25
106
74
-79
24
-98
6

Mutual Funds that own Altimmune Stock

Check out the Mutual Funds with significant holdings in Altimmune.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.839845%
5522765
VANGUARD HORIZON FUNDS
1.266456%
2462930
TIAA-CREF Funds
1.187122%
2308646
Fidelity Salem Street Trust
0.724947%
1409835
VANGUARD EXPLORER FUND
0.623997%
1213513

Global Institutional Holdings in Altimmune

Funds
Holdings
iShares
4.95%
Vanguard
5.08%
SPDR
4.55%
Fidelity
0.69%
Dimensional
0.24%

Insights on Altimmune

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 5.0K → 26.0K (in $), with an average increase of 80.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ALT stock has moved up by 8.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 624.7% return, outperforming this stock by 607.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 493.6% return, outperforming this stock by 507.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -22.56M → -22.82M (in $), with an average decrease of 1.2% per quarter

About Altimmune

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
OrganisationAltimmune
Headquarters910 Clopper Road, Gaithersburg, MD, United States, 20878
IndustryBiotechnology
CEOMr. Jerome Benedict Durso
E-voting on sharesClick here to vote

Key Management of Altimmune

Name

Title

Mr. Gregory L. Weaver CPA, M.B.A.

Chief Financial Officer

Mr. Andrew Shutterly M.S.

Principal Financial & Accounting Officer and Corporate Controller

Mr. Bertrand Georges Ph.D.

Chief Technology Officer

Mr. Jerome Benedict Durso

Chairman, CEO & President

Dr. M. Scot Roberts Ph.D.

Chief Scientific Officer

Dr. Christophe Arbet-Engels M.B.A., M.D., Ph.D.

Chief Medical Officer

FAQs

What is Altimmune share price today?

Altimmune share price today is $2.94 as on . Altimmune share today touched a day high of $3.08 and a low of $2.92.

What is the 52 week high and 52 week low for Altimmune share?

Altimmune share touched a 52 week high of $6.44 on and a 52 week low of $2.56 on . Altimmune stock price today i.e. is trending at $2.94,which is 54.35% down from its 52 week high and 14.84% up from its 52 week low.

What is Altimmune's market capitalisation today?

Altimmune market capitalisation is $0.00T as on .

How to invest in Altimmune Stock (ALT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Altimmune on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Altimmune Shares that will get you 0.5102 shares as per Altimmune share price of $2.94 per share as on August 20, 2026 at 11:57 pm IST.

What is the minimum amount required to buy Altimmune Stock (ALT) from India?

Indian investors can start investing in Altimmune (ALT) shares with as little as ₹95.695 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.95 in Altimmune stock (as per the Rupee-Dollar exchange rate as on ). Based on Altimmune share’s latest price of $2.94 as on August 20, 2026 at 11:57 pm IST, you will get 3.4014 shares of Altimmune. Learn more about fractional shares .

What are the returns that Altimmune has given to Indian investors in the last 5 years?

Altimmune stock has given -75.6% share price returns and 28.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?